CUSIP: 04746L203 | NYSE | Healthcare · Biotechnology | Micro Cap | 58 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 149,279 | $532.9K | 0.0% | Core | Low | Las Vegas, NV | 2026-10-27 | |
| 85,336 | $304.8K | 0.0% | Index | Very Low | Boston, MA | 2026-11-06 | |
| 19,381 | $69.2K | 0.0% | Index | Low | Austin, TX | 2026-11-04 | |
| 200 | $714 | 0.0% | ETF | Low | Ketchum, ID | 2026-10-28 | |
| 81 | $289 | 0.0% | Index | Low | Minneapolis, MN | 2026-11-05 | |
| 12 | $43 | 0.0% | Agg Growth | Low | Tokyo, Mexico | 2026-10-22 | |
| 2 | $7 | 0.0% | Core | Medium | London, United Kingdom | 2026-11-06 | |
| 1 | $4 | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 |
| No 13F filer matched |
| 13D/APerceptive Advisors LLC with Perceptive Life Sciences Master Fund, Ltd., Perceptive Xontogeny Venture Fund II, LP | 1,889,403 | 20.0% | Unchanged | Oct 26, 2026 | 1,859,322 sh (Jun 30, 2026) |
| 13G/AAnders Hove with Acorn Capital Advisors GP 2, LLC, Acorn Bioventures 2, L.P., Acorn Bioventures, L.P., +1 more | 1,492,521 | 12.1% | New 5%+ stake | Aug 18, 2026 | No 13F filer matched |